Archive for March, 2009

How Kington Portrays NIH ARRA Spending to Congress

In his March 26th testimony to the House Subcommittee on Labor-HHS-Education Appropriations, Ray Kington (Acting NIH Director) expressed his gratitude for the $10.4B in stimulus funding and the whooping 3.2% increase in the FY09 appropriation. He shares a heart-warming story of stimulus funds already saving the economy (excerpt from an e-mail to an IC director):

“Forgot to say that we gave a termination letter last Friday to my longtime (5 years) postdoc. His job has been saved. He is going to be thrilled to hear about his change in fortune! I also would like to hire a technician with the new funds, since at present I do not have one.”

An NIH-funded researcher with a post-doc but no lab tech? Never mind.

First, I’ll jump ahead to as-yet un-announced opportunities: Read the rest of this entry »

Comments (7)

It’s Baaaack … the ARRA P30 RFA that is

This time, they’re calling a spade a spade:

Supporting New Faculty Recruitment to Enhance Research Resources through Biomedical Research Core Centers (P30)

LOIs due April 29th, applicatons due May 29th. Approximately $100 million of ARRA funds will be obligated by September 30, 2010. These remain 2-year awards given on the basis of a 12-page research narrative (details in RFA).

Allowable Costs: Salaries & fringe for newly hired/promoted investigators, start-up packages, “research resources that facilitate a multidisciplinary approach to the Center’s research efforts”

Unallowable Costs: Recruitment costs (advertising, travel, etc.), construction-renovation of lab-office space, “Salary support for teaching, clinical or other non-research activities“, “Salary and administrative support costs for the PD/PI”

Who’s playing and what are their terms (and contact personnel)? Read the rest of this entry »

Comments (1)

ClinicalTrials.gov Meeting – Publicly Available Trial Data

On Monday, April 20th, the NIH will hold a public meeting to discuss the expansion of ClinicalTrials.gov as required by the FDA Amendments Act of 2007. You can register to attend in person or watch via videocast. You can submit comments online to Docket No. NIH-2009-0002 as well. Read the rest of this entry »

Comments (1)

Special NCRR Supp Opportunity to Leverage CTSAs etc.

This special NCRR competitive revision application, which has as second submission date even (April 21 and July 10), may have slipped under the radar in many places, so I’ll call out some pertinent details here. You must download the How To Apply PDF. PIs with active R01s will need to work with their PO and the appropriate NCCR center/center-like entity (CTSA, GCRC, SEPA, BTRC, primate center, etc.) in planning requests.

NCRR will commit $20M to these supplements. The maximum direct cost per award allowed by NCRR is $300K. The budget should be appropriate for the proposed work and my be limited by the parent IC restrictions on the size of competitive revision awards. You should talk with your PO or check your IC Website for details.

You can request funding to support:

• Training Opportunities
• Technology sharing
• Equipment sharing
• Outreach Projects
• Animal model development
• Study design support
• Computational modeling
• Clinical support
• Technology transfer support
• Translational research studies

and then some. Please remember that these requests must be to support new research objectives/experiments outside of the original scope of your parent grant.

When actually applying, you MUST include the phrase “Enabling RPGs to Leverage NCRR Center and Center-like Programs” in two places:

  • Include a Cover Letter and cite the Notice Number (NOT-OD-09-058) and the NCRR Notice title: Enabling RPGs to Leverage NCRR Center and Center-like Programs in the first sentence. If the title of this announcement is not included, NCRR will not consider the application.
  • Explicitly cite the Notice Number (NOT-OD-09-058) and Notice Title: Enabling RPGs to Leverage NCRR Center and Center-like Programs in the first sentence of the Project Summary/Abstract Component of the application. If the title of this announcement is not included, NCRR will not consider the application.

Leave a Comment

Core Center Grant Focused on Supporting-Recruiting New Investigators

LATEST UPDATE: The NIH released the replacement ARRA P30 RFA, which is summarized above. Read the rest of this entry »

Comments (6)

More “Grand Opportunities” (GO!)

The OD, with participation by NCI, NHLBI, NHGRI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDCR, NIDA, NIGMS, NIMH, NINDS, NCCAM, NCMHD, have designated at least $200 million in FYs 2009 – 2010 to fund 200 or more grants in response to:

Research and Research Infrastructure “Grand Opportunities” (RC2)
LOI due April 27, Applications due May 27
IC-specific info at http://grants.nih.gov/recovery/ic_go.html Read the rest of this entry »

Comments (2)

ARRA RFAs Being Released

The ICs are beginning to release RFAs to spend more of their stimulus funding …

NIMH, NICHD, NIDCD, NIEHS, & NINDS will commit ~$57M to fund between 40-50 grants in response to the 4 funding mechanisms available for Research to Address the Heterogeneity in Autism Spectrum Disorders (R01, collaborative R01, R21, R34 & collaborative R34) – LOI due April 12, Application due May 12 – please note that the ICs listed above do not all participates in each funding mechanism

Leave a Comment

NSF ARRA Update

Last week, the NSF distributed and then removed an ARRA-related Dear Colleague letter. Yesterday, Arden Bemet (NSF Director) issued Important Notice No. 131 in which he noted, among other things:

The Recovery Act supplements NSF fiscal year 2009 funding by $3.0 billion. NSF currently has many highly rated proposals that it has not been able to fund. For this reason, NSF is planning to use the majority of the $2 billion available in Research and Related Activities for proposals that are already in house and will be reviewed and/or awarded prior to September 30, 2009. Read the rest of this entry »

Comments (4)

Stimulated NIH Supplement Funding Opportunities

Update: I’m adding supplement request deadlines and links to my ARRA Resources Page for each IC as they come online.

Per the NIH Guide, ~$1 billion of ARRA funds will be obligated by September 30, 2010 to support requests submitted in response to supplement requests that, interestingly, can be applied to awards under no-cost extensions. Note the April 21st deadline for the Competitive Revision Applications (support for a significant expansion of the scope or research protocol of an existing award); receipt date is open for administrative and summer research experience supplements. For all of these, grantees must comply with all ARRA requirements, including, but not limited to, the quarterly reporting requirements. Oh joy. You submit your requests to your IC, not CSR.

Some ICs will consider administrative supplements only in target areas identified on their IC Supplement Website. Read the rest of this entry »

Comments (12)

Beware of Grant-Writing Mercenaries

Writedit, who supports biomedical researchers at an academic medical center – investigators to whom writedit is fiercely loyal – was dismayed to discover this blog is being devoured by inexperienced grant-writing mercenaries seeking to make a quick buck writing Challenge Grant proposals: Read the rest of this entry »

Comments (22)

Older Posts »